The next batch of AVAC live vaccines from Vietnam may arrive in the country next month, the Department of Agriculture (DA) ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a narrow economic moat. Growth of existing products and new product launches should help offset ...

The deal complements an existing partnership with Novavax that encompasses R&D of combination vaccines for Covid-19 and flu.

Paris-based drugmaker Sanofi is acquiring U,K,-based Vicebio to gain its molecular clamp vaccine technology, with the total ...

Respiratory vaccines specialist Vicebio Ltd. is to be acquired by Sanofi SA in a $1.6 billion deal, of which $1.15 billion ...

The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.

President Trump said he's secured a trade deal with Vietnam in what would be just the second agreement Trump has made with another country.

The Trump administration’s vaccine advisers are bringing up an old debate: whether it’s time to wipe out the last small fraction of those vaccines that contain a controversial preservative.

Novavax’s partnership with Sanofi allows the pharma giant to explore potential combinations of assets from both companies, and it’s a blueprint for the kinds of alliances the vaccine developer ...